AICDA and urinary bladder cancer: Revealing AID’s gene expression regulatory mechanism suggests the off-target effect of AID in the tumorigenesis of various cancers, such as colorectal cancers (34), breast cancers (91), gastric cancers (95), bladder cancers (96), lung cancers (97), melanoma (98), and others.